Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 5, 2009Lupus

Efficacy and safety of infliximab in active SLE: a pilot study

View Full Paper
Ask AI
Bookmark
Share

Authors

SUSS UppalSHS. H. M. HayatRRRaj RaghupathyKuwait University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Uppal et al. (2009) studied this question.

synapsesocial.com/papers/6aa8437cb6fbb14f4a981504https://doi.org/10.1177/0961203309102557
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The MOS 36-ltem Short-Form Health Survey (SF-36)1992 · 30,291 citations
  2. 2Strong and Selective Glomerular Localization of CD134 Ligand and TNF Receptor-1 in Proliferative Lupus Nephritis2000 · 113 citations
  3. 3Effects of short‐term infliximab therapy on autoantibodies in systemic lupus erythematosus2006 · 111 citations
  4. 4Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation11999 · 92 citations